慢性淋巴细胞白血病中t(14;18)(q32;q21)/IGH::MALT1的新型识别
慢性淋巴细胞白血病(CLL)中涉及IGH易位不常见,本文首次报道两例携带t(14;18)(q32;q21)/IGH::MALT1的CLL患者,两例均与较低危生物学参数相关,作者建议对IGH易位伙伴未知的CLL病例开展MALT1的FISH检测。
要点
- 首次报道两例CLL患者携带t(14;18)(q32;q21)/IGH::MALT1。
- 两例均与较低危生物学参数相关。
- 作者建议对IGH易位伙伴未知的CLL病例行MALT1的FISH检测。
核心结论
- 本文首次报道两例携带t(14;18)(q32;q21)/IGH::MALT1的CLL患者,两例均与较低危生物学参数相关。
- 作者建议对IGH易位伙伴未知的CLL病例在临床实践中开展MALT1的FISH检测以更好地定义此类病例。
研究设计与样本
- 本文为病例报告,描述两例携带t(14;18)(q32;q21)/IGH::MALT1的CLL患者。
主要发现
- 两例CLL患者均记录到t(14;18)(q32;q21)/IGH::MALT1。
- 两例均与较低危生物学参数相关。
临床怎么用
- 作者建议对IGH易位伙伴未知的CLL病例在临床实践中开展MALT1的FISH检测。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Chronic lymphocytic leukaemia (CLL) is a clonal B-cell malignancy and remains a chronic disease despite improvements in clinical outcomes since the use of targeted therapies. Both clinical and biological parameters are important for determining prognosis. Unlike other mature B-cell lymphomas, translocations involving the immunoglobulin heavy chain (IGH) locus are uncommon in CLL. There have been few case reports of CLL harbouring t(14;18)/IGH::BCL2 and t(14;19)/IGH::BCL3. Here we describe the first two cases of patients with CLL with documented t(14;18)(q32;q21)/IGH::MALT1. Both cases in this report were associated with lower-risk biological parameters. Thus, FISH testing for MALT1 in cases with unknown IGH translocation partners in the setting of CLL should be implemented in clinical practice to better define such cases.
引用
- Kumar J, Ewalt MD, Zhang Y, et al. Novel identification of t(14;18)(q32;q21)/IGH::MALT1 in chronic lymphocytic leukaemia. Br J Haematol. 2023. PMID: 38031233. doi:10.1111/bjh.19235
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。